+917069000000 info@cims.org

DR. URMIL SHAH

Dr. Urmil Shah

Dr. Urmil Shah

Dr. Urmil Shah

Interventional Cardiologist

MD, DM (CARDIOLOGY), FACC

Cardiology

 urmil.shah@cims.org

+91 9825066939

CURRICULUM VITAE     

NAME : SHAH URMIL GIRISHBHAI,

MD, DM (Cardiology), FACC

CONTACT DETAILS:

Office:

Care Institute of Medical Sciences

Nr. Shukan Mall

Off Science City Road, Sola

Ahmedabad- 380060, Gujarat, India

Mobile:  +91-9825066939 (Personal)

              +91-9825066664, 9825066668 

Email: urmil.shah@cims.me

Website : www.indianheart.com

DATE OF BIRTH       : 25th September 1967.

NATIONALITY       : Indian.

NATIVE PLACE       : Ahmedabad.

Name of Wife : Dr. Manisha Shah

                                                           M.D (Pathology)

Children                            :           Two

                                                           1. Kaivaan Shah  (Male)     Age-      13    (as in 2012)

                                                           2. Manvi Shah    (Female) Age-       09   (as in 2012)

EDUCATION

Pre-university       : Passed Higher Secondary Examination in 1984.

University Examination: Studied in Faculty of Medicine.

M.B.B.S.

M. D. (Internal Medicine)

D. M.   (Cardiology)

Exams University Passed In marks obtained/ Attempt

      Year       out of

First Gujarat University Feb. 1986. 435/750 First

M.B.B.S. Ahmedabad.

Second             Gujarat University Nov. 1987. 367/600 First

M.B.B.S. Ahmedabad.

Third Gujarat University May 1989. 608/1000 First

M.B.B.S. Ahmedabad.

M.D. Gujarat University April 1993. 507/1000 First

(Int. Med.) Ahmedabad.

D.M. Gujarat University Sep. 1996. 525/1000           Second

(Cardiology) Ahmedabad.

MEDICAL COUNCIL No.G.18727; 2nd August 1990.

REGISTRATION Additional No: 5586, 31st may 1993.

CURRENT AFFILIATION

  1. Director, CIMS Hospital, Ahmedabad, India
  2. Consultant and Interventional Cardiologist at CIMS Hospital, Ahmedabad, India

FACC – 2015

EXPERIENCE:

  1. Rotating Internship from 07.07.1989 to 06.07.1990 (One year)
  2. Resident in Medicine Department, Civil Hospital, Ahmedabad, 380016.
  3. Out of these three years of residency, specialized training in various
  4. departments like Cardiology, Nephrology, Cancer, Gastro-enterology, and Emergency medicine.
  5. This intensive training in General Medicine and related specialities included emergency medicine, and involvement in regular teaching of under-graduate students.

EXPERIENCE (After M.D. Degree)

ALL TEACHING INSTITUTIONS-UNIVERSITY HOSPITALS

Post Department Hospital/Teaching Period Duration

        Institution

Senior Cardiology U.N.Mehta Heart 27.01.94             2 yrs

Resident Department Hospital     to      

Civil Hospital 26.01.96

Research Cardiology Institute of Cardiology 14.04.96        1 & 1/2

Fellow Department and Research Center,     to                Yrs

B. J. Medical College, 16 09 97

Ahmedabad.

Assistant Cardiology Institute of Cardiolog 16 9 1997

Professor Department and Research Center,      to                            4 yrs

B.J. Medical College, 23 07 2001   

Ahmedabad.

 

Past Director  & Consultant   Sterling Hospital   2001 to 2004 4 yrs

Affiliation Cardiologist

Past Consultant SAL Hospital   2004 to 2009 5 yrs

Affiliation Cardiologist Apollo Hospital

V.S. General Hospital

Current Director & Consultant CIMS Hospital   2009 to till today

Affiliation Cardiologist

Formerly affiliated to V.S. General Hospital

The experience as a Senior Resident in Cardiology entailed extensive training in:

  • Clinical Cardiology, with case study and management of all varieties of patients with Cardiac ailments.
  • All routine non-invasive cardiac investigation including exercise stress testing, Holter monitoring and echocardiography with color Doppler imaging.
  • Cath. Lab procedures including cardiac catheterization angiography, coronary angiography, pacemaker, valvuloplasty, peripheral and coronary angioplasty and other related invasive therapeutic interventions. Thus also entails active participation in temporary and permanent cardiac pacemaker implantations.
  • All bedside invasive procedures including pericardiocentesis, temporary cardiac pacing, and hemodynamic monitoring during ICCU care.
  • Routine pre-operative evaluation and active involvement in peri-operative management of all closed and open-heart surgical patients.
  • Regular teaching of undergraduate and postgraduate students in different aspects of clinical cardiology.

PRACTICAL PROCEDURES PERFORMED:

Involved in more than 30000 cardiac catheterization and angiography procedures. This includes:

  • Coronary angiography. (>20000)
  • Pediatric cardiac catheterization. (>1500)
  • Valvuloplasties including balloon, mitral, aortic and pulmonary valve dilatation. (>2000)
  • Peripheral angioplasties including renal angioplasties and  carotid stenting (>100)
  • Coronary intervention.

PTCA (>5000)

Stents (>5000)

                  PAMI                                                              (>1000)

Directional Atherectomy. (>15)

Rotational Atherectomy (>10)

Graft vessel intervention with filter device (>50)

  • Carotid Stenting >30
  • Peripheral  Stenting >50
  • Renal Stenting >50
  • ASD Device >5
  • PDA coil Closure  >75
  • PDA Amplatzer device  >40
  • Balloon dilatation and stenting of Coarctation of Aorta
  • Permanent pacemaker implantation including Dual Chamber Pacing > 100

NONINVASIVE PROCEDURE

         Color Doppler echocardiography          >35000         

         Pediatric Echocardiography                  > 6000

         Trans Esophageal Echocardiography   >500

         Dobutamine Echocardiography             >500 

         Intra-operative Echocardiography         >50

   Stress test                                             > 2500

         Holter test                                              >250

         Head Tilt table test                                >50

RESEARCH EXPERIENCE/SCIENTIFIC PUBLICATIONS:

  • Thesis/Dissertation submitted to Gujarat University for the degree of M.D. (General Medicine) in 193. “Clinical Profile of Mediastinal Mass”.

  • Thesis/Dissertation submitted to Gujarat University for degree of D.M. (Cardiology) in 1995. “Immediate and short term outcome of patients undergoing PTCA – a study of 232 lesions in 200 patients.

  1. Dani S I, Chag M C, Patel T M, Shah S C, Shah U G, Thakore S B, Patel T K : PTMC for juvenile rheumatic mitral stenosis. Ind Heart J :  47: 6 : 79; 1995(abstract).
  2. Patel T M, Dani S I, Chag M C, Shah S C, Shah U G, Thomas V M, Patel T K : How to minimise radiation to foetus during balloon mitral valvuloplasty in pregnant women. Ind Heart J :  47: 6 : 80; 1995(abstract).
  3. Chag M C, Patel T M, Dani S I, Thomas V M, Shah U G, Jain S, Patel T K : Balloon aortic valvuloplasty for severe aortic stenosis. Ind Heart J :  47: 6 : 163; 1995(abstract).
  4. Chag M C, Dani S I, Patel T M, Shah S C, Shah U G, Thomas V M, Patel T K : Balloon angioplasty  for native coarctation of aorta beyond infancy. Ind Heart J :  47: 6 : 164; 1995(abstract).
  5. Patel T M, Dani S I, Chag M C, Shah S C, Shah U G, Thakore S B, Rawal J R, Patel T K : Technical challenges in PTCA with reused hardware. Ind Heart J :  47: 6 : 219; 1995(abstract).
  6. Patel T M, Dani S I, Chag M C, Shah S C, Shah U G, Patel T K : Crossing of mitral orifice with the Inoue balloon : the straight balloon technique. Cathet Cardiovasc Diagn 37 : 231-232, 1996.
  7. Dani S I, Patel T M, Rawal J R, Shah S C, Shah U G, Jain S, Patel T K : Elective primary stenting for complex coronary lesions : clinical and angiographic follow up. Ind Heart J :  48: 5 : 164; 1996(abstract).
  8. Patel T M, Dani S I, Rawal J R, Shah U G, Thomas V M, Baxi H, Patel T K : Balloon mitral and aortic valvuloplasty in mirror-image dextrocardia. Ind Heart J :  48: 5 : 240; 1996(abstract).
  9. Patel T M, Dani S I, Chag M C, Thakore S B, Shah S C, Shah U G, Patel T K : Balloon mitral and aortic valvuloplasty in mirror image dextrocardia. J Invas Cardiol 8 : 164-168, 1996.
  10. Patel T M, Dani S I, Shah S C, Shah U G, Patel T K : Balloon pulmonary valvuloplasty using the Inoue catheter : A novel ‘free-float’ Inoue technique. J Invas Cardiol, Oct.1996.
  11. Balloon Mitral Valvuloplasty in Calcific Mitral Stenosis : Immediate and Mid Term Results : Bhupesh Shah, Sameer Dani, Jayesh Rawal, Urmil Shah, Vipin Thomas, Sharad Jain. Institute of  Cardiology and Research Centre, Ahmedabad. Indian Heart J 1997 ; 49 : 629. IHJ, Nov-Dec. 1997.
  12. Multitrack System for Balloon Mitral Valvuloplasty : Initial Results : Jayesh Rawal, Sameer Dani, Bhupesh Shah, Urmil Shah, Institute of Cardiology and Research Centre,Ahmedabad.Indian Heart J 1997 ; 49 : 630. IHJ, Nov-Dec. 1997.
  13. Concurrent Multivalvular Balloon Dilatation : Acute Results and Short Term Follow-up : Urmil Shah, Sameer Dani, Bhupesh Shah, Jayesh Rawal, Sharad Jain, Jayesh Prajapati, Anish Chandarana, Hasit Joshi, Institute of Cardiology and Research Centre, Ahmedabad.Indian Heart J 1997 ; 49 : 633. IHJ, Nov-Dec. 1997.
  14. Pura Vario – A Poor Man’s Stent : Six Months Clinical and Angiographic Follow – up : DR Solanki, SI Dani, BR Shah, UG Shah, SR Jain, J Prajapati, A Chandarana. UN Mehta Institute of Cardiology and Research Centre, Civil Hospital, Ahmedabad. Indian Heart J 1998 ; 50 : 639. IHJ, Nov-Dec. 1998.
  15. Intracoronary “Saint Come” Stents : Short and Mid-Term Follow-up Results : BR Shah, SI Dani, UG Shah, SR Jain, DR Solanki, H Baxi, A Chandarana. Department of Cardiology, UN Mehta Institute of Cardiology and Research Centre, Civil Hospital,Ahmedabad.Indian Heart J 1998 ; 50 : 639. IHJ, Nov-Dec. 1998.
  16. Non-Surgical Mitral Commissurotomy Using A New Metallic Dilator : SI Dani, SR Jain, BR Shah, UG Shah, J Prajapati, DR Solanki, H Joshi, UN Mehta Institute of Cardiology and Research Centre, Civil Hospital, Ahmedabad.Indian Heart J 1998 ; 50 : 645. IHJ, Nov-Dec. 1998.
  17. Combination of Plain PTCA with Stenting in Coronary Artery Disease : Immediate and Intermediate – Term Outcome. SI Dani, BR Shah, UG Shah, SR Jain, H Baxi, A. Chandarana UN Mehta  Institute Of Cardiology  and Reserch center , Civil Hospital, Ahmedabad . Indian Heart Journal 1998; 50 : 663. IHJ , Nov-Dec. 1998.
  18. Retrieval Of Foreign Material From Vascular System: An Appraisal of  arious retrival devices:SI Dani, DR Solanki, BR Shah , UG Shah , SR Jain, H baxi ,H. Joshi   UN Mehta Institute  of  Cardiology and Reserch Center,Civil Hospital Ahmedabad .Indian Heart Journal 1998;  50 : 675. IHJ , Nov – Dec  1998
  19. Ballloon Dilatation  of Coarctation  of Aorta  in  adults: Immediate and   Folllow Up  ;SI Dani , BR Shah,UG Shah. DR Solanki, J Prajapati , A Chandarana  UN Mehta   Institute  of Cardiology and Reserch Center.Ahmedabad. Indian Heart Journal 1998 ;  50 : 691.  IHJ Nov – Dec 1998
  20. Left  Main Coronary  Artery   disease   in Gujarati Population., SI Dani , Jayesh Rawal Bhupesh  Shah, Urmil Shah,Sharad Jain, Jayesh Prajapati , Hemang Baxi, Anish Candarana, Hasit Joshi . Paper Presented in 19 APGCON  3-4 jan    1998;   Ahmedabad, Gujarat.
  21. Immediate and Short Term Outcome of Patient Undergoing  Plain  PTCA  SI Dani , Jayesh Rawal Bhupesh  Shah, Urmil Shah,Sharad Jain, Jayesh Prajapati , Hemang Baxi, Anish Candarana, Hasit Joshi . Paper Presented in 19 APGCON  3-4 jan    1998;   Ahmedabad, Gujarat.
  22. Stent Implantation in Coronary Artery Disease:  Acute and Mid Term Results SI Dani , Jayesh Rawal Bhupesh  Shah, Urmil Shah,Sharad Jain, Jayesh Prajapati , Hemang Baxi, Anish Candarana, Hasit Joshi . Paper Presented in 19 APGCON  3-4 jan    1998;   Ahmedabad, Gujarat.
  23. Pulmonary Stenosis : Long term  Results of Balloon Dilation SI Dani , Jayesh Rawal Bhupesh  Shah, Urmil Shah,Sharad Jain, Jayesh Prajapati , Hemang Baxi, Anish Candarana, Hasit Joshi . Paper Presented in 19 APGCON  3-4 jan    1998;   Ahmedabad, Gujarat.
  24. Balloon Dilatation of Coarctation of AORTA: Immediate results and Intermediate Follow Up SI Dani , Jayesh Rawal Bhupesh  Shah, Urmil Shah,Sharad Jain, Jayesh Prajapati , Hemang Baxi, Anish Candarana, Hasit Joshi . Paper Presented in 19 APGCON  3-4 jan    1998;   Ahmedabad, Gujarat.
  25. Permanent Pacemaker  Implatation In  Gujarat: A Single Center Experience SI Dani, Jayesh Rawal Bhupesh  Shah, Urmil Shah,Sharad Jain, Jayesh Prajapati , Hemang Baxi, Anish Candarana, Hasit Joshi . Paper Presented in 19 APGCON 3-4 Jan 1998;   Ahmedabad, Gujarat.
  26. Comparision of  Intravenous nicorandil  with Intravenous  Nitroglycerine in Patients with Unstable Angina .UG Shah , S Jain , P Jethavani , S Thanvi , BR shah,  SI Dani  UN Mehta  Institute of Cardiology  and Reserch Center ,civil Hospital Ahmedabad.  Indian Heart Journal 1999 ; 51 : 704 . IHJ  Dec  1999 
  27. Economical  Consideration in  Percutaneous  Dilatation of Mitral  Valve  by Different Device and Hardware  JR Rawal , UG Shah,  JS Prajapati , BR Shah,  AH Chandarana , SI Dani   UN  Mehta Institute of Cardiology and  Research  Center ,  Civil Hospital  Ahmedabad. Indian Heart Journal 1999 ; 51: 723. IHJ  Dec 1999 
  28. Five Year Follow up after Inoue Balloon Mitral Valvuloplasty in Juveniles . JR Rawal, JS Prajapati, UG Shah , S Jain, SI Dani    UN  Mehta Institute  of Cardiology and Research Center,  Civil Hospital, Ahmedabad. Indian Heart Journal 1999; 51 732. IHJ Dec  1999
  29. B.C. Kaji,  G.R. Bhagat.  Shah U.G.  A study of 66 cases of mediastinal mass. Indian Journal of Internal Medicine,1993,No-8-10,248-253.

  1. Dani S.I. Patel T.M., Chag M.C., Thakore S.B., Shah U.G., Patel T.K., Balloon Valvulopasty in adult pulmonary stenosis. Indian Heart Journal 1994, Vol.46, No.5,252(abstract).

  1. Parikh KH, Chag M C, Shah UG, Baxi HA, Chandarana AH, Naik A M, Shah KJ. Acute Results and Intermediate term Follow-up of PCI with Cardio Protection by Balloon Occlusion Distal Protection Device (Abstract). Indian Heart J-233, 2002 54:561-568.

  1. Shah KJ, Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Goyal RK. Prevalence of Hyper–homocysteinemia in Western Indian Population with or Without Coronary Artery Disease Indian Journal of Cardiology 2003;6:54-58.

  1. Parikh KH, Shah KJ, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Goyal RK. Reversal of Slow-Flow or No-Reflow During PTCA Using Boluses of IC Adenosine and Sodium Nitroprusside in Combination. Suppl. To JACC, Mar 19, 2003; 41(6), Suppl.A-1101-

  1. Shah HD, Iyer S, Shah K, Parikh K, Chag M, Shah U, Baxi H, Chandarana A, Naik A, Goyal RK. Effect of Statins in Combination with Fenofibrate in Patients after Percutaneous Transluminal Coronary Angioplasty. Indian Journal of Pharmacology 2004;36(2):113.

  1. Parikh KH,Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah HD, Goyal RK. Beneficial Effects of Distal Protection Device in Reducing the Use of Intracoronary Vasodilators and Glycoprotein IIb/IIIa Receptor Antagonists During Percutaneous Coronary Interventions. Catheterization and Cardiovascular Interventions 2004;62:90. (Abstract)

  1. Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Goyal RK. Revascularization in Acute Myocardial Infarction Using Percusurge in Distal Protection (RAPID) (Abstract). Catheterization and Cardiovascular Interventions 2004;62:116.

  1. Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah HD, Goyal RK. Improvement in MACE by Sequentia Administration of Boluses of Intracoronary Adenosine and Sodium Nitroprusside during Percutaneous Coronary Interventions. Catheterization and Cardiovascular Interventions2004;62:130-131.

  1. Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah HD, Shah KJ, Shah JN, Goyal RK. Improvement in MACE by Sequential Administration of Boluses of Intracoronary Adenosine and Sodium Nitroprusside during Percutaneous Coronary Interventions. ESC Congress 2004: Abstract: P3045.

  1. Chag MC, Parikh KH, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Shah HD, Shah KJ, Goyal RK. Increased Lipoprotein as a Strong Risk Factor for Coronary Artery Disease and the Effect or Niacin Amongst Indians. Indian Heart J 2004;56(5):377-599.

  1. Chag MC, Shah HD, Joshi MV, Parikh KH, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Goyal RK. Renal Artery Stenting is Safe and Effective Modality of Treatment on Mid-term Follow-up. Indian Heart J 2004;56(5):377-599.

  1. Mehta KN, Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Goyal RK. Effect of Folate Treatment on Homocysteinemia in Cardiac Patients: A Prospective Study. Indian Journal of Pharmacology 2005;37:13-17.

  1. Shah HD, Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Patel GT, Mathan G, Shah JN, Goyal RK. Association of White Blood cell count with the Occurrence of slow/no reflow in acute coronary Syndrome patients undergoing PCI. Poster presentation at Joint International Conference of ISHR and IACS, Jan 2005, Gujarat, India.
  2. Shah HD, Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Patel GT, Mathan G, Shah JN, Goyal RK. Efficacy of Percusurge Guardwire system in acute Myocardial patients undergoing Primary/rescue PCI. Oral Presentation at Joint International Conference of ISHR and IACS, Jan 2005, Gujarat, India.

  1. Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Beneficial effects of Distal Protection device in reducing the use of Intracoronary Vasodialators and Glycoprotein IIb/IIIa receptor antagonists during Percutaneous Coronary Interventions. (Accepted for Poster Presentation) Annual conference of Society of Cardiovascular Angiography and Interventions (SCAI) 2004

  1. Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Improvement in MACE by sequential administration of boluses of Intracoronary Adenosine and Sodium Nitroprusside during Percutaneous Coronary Interventions. (Accepted for Poster Presentation) Annual conference of Society of Cardiovascular Angiography and Interventions (SCAI) 2004

  1. Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Revascularization in Acute Myocardial Infarction using PercuSurge in Distal Protection. (Accepted for Poster Presentation) Annual conference of Society of Cardiovascular Angiography and Interventions (SCAI) 2004

  1. Chag M.C., Shah H. D., Parikh K.H., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Increased Lipoprotein (a) as a strong risk factor for Coronary Artery Disease and the effect of Niacin amongst Indians. European Society of  Cardiology (Submitted) 2004.

  1. Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Beneficial effects of Distal Protection device in reducing the use of Intracoronary Vasodialators and Glycoprotein IIb/IIIa receptor antagonists during Percutaneous Coronary Interventions. European Society of Cardiology (Submitted) 2004.

  1. Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Improvement in MACE by sequential administration of boluses of Intracoronary Adenosine and Sodium Nitroprusside during Percutaneous Coronary Interventions. European Society of Cardiology (Submitted) 2004.

  1. Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Revascularization in Acute Myocardial Infarction using PercuSurge in Distal Protection. European Society of Cardiology (Submitted) 2004.

  1. Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Effect of combination of statins and fenofibrate with acute coronary syndrome undergoing Percutaneous Coronary Interventions. European Society of Cardiology (Submitted) 2004.

  1. Chag MC, Shah HD, Joshi MV, Parikh KH, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah   JN, Goyal RK. Renal artery stenting is safe and effective modality of treatment on mid term follow up. 2004

  1. Shah HD, Iyer S, Shah K, Parikh K, Chag M, Shah UG, Baxi H, Chandarana A, Naik A, Goyal RK. Effect of Statins in combination with fenofibrate in patients after percutaneous transluminal coronary angioplasty,2004

  1. Mehta K N, Parikh K H, Chag MC, Shah U G, Baxi H A, Chandarana A H, Naik A M, Goyal R K, Effect of Folate Treatment on Homocysteinemia in Cardiac Patients: A Prospective Study,2005.

  1. Shah HD, Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Patel     GT, Mathan G, Shah JN, Goyal   RK,  Association of White Blood cell count with the Occurrence of slow/no reflow in acute  coronary Syndrome patients undergoing PCI.2005.

  1. Shah HD, Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Patel GT, Mathan G, Shah JN, Goyal    RK, Efficacy of Percusurge Guardwire system in acute Myocardial patients undergoing Primary/rescue PCI.2005.

  1. Kanan Shah, Keyur Parikh, Milan Chag, Urmil Shah, Anish Chandarana, Hemang Baxi, Ajay Naik, Ramesh K. Goyal, Avigilance study of distal protection device used during Percutaneous coronary interventions. 2006

  1. KH Parikh, HA Shah, UG Shah, HA Baxi, AH Chandarana, AM Naik, JN Shah, MP Tanna, MC Chag,  Initial Clinical experience with Bivalirudin as an anticoagulant during percutaneous coronary interventions in Asian Indian patients,2006

  1. KH Parikh, HA Shah, JN Shah, UG Shah, HA Baxi, AH Chandarana, AM Naik, RK Goyal, MC Chag, Prospective randomized study of PercuSurge in Acute Myocardial Infarction Patients undergoing Revascularization with a special Emphasis on Procedural Time: A Two Year Follow-up. 2006

  1. Chandarana AH, Shah JN, Shah HA, Shah UG, Baxi HA, Naik AM, Joshi M, Goyal RK, Parikh KH, Chag MC. High Prevalence Of Renal Artery Stenosis In Hypertensive Patients With Triple Vessel Coronary Artery Disease: Recommendation For Simultaneous Renal Arteriogram For Earlier Intervention.2006

  1. HA Shah, JN Shah, AH Chandarana, MC Chag, UG Shah, HA Baxi, AM Naik, KH Parikh, RK Goyal. Association between the White Blood Cell Count and Occurrence of Slow or No Reflow Phenomenon in Patients with Acute Coronary Syndromes in the coronary Interventional Era,2006

  1. HA Shah, MC Chag, MP Tanna, UG Shah, HA Baxi, AH Chandarana, AM Naik, JN Shah, KH Parikh. Incidences and Clinical Characteristics of No Reflow after Percutaneous Coronary Interventions in High Risk Asian Indian Patients. 2006

  1. K. Parikh, AM Naik, HA Shah, AH Chandarana, MC Chag, UG Shah, HA Baxi, JN Shah, A Medina, S Banai, First In Man: Direct Comparison Of Conventional Coronary Sinus Angiography And CT Angiography For Visualization And Sizing Of Coronary Sinus,2006

  1. K. Parikh, HA Shah, AH Chandarana, AM Naik, MC Chag, UG Shah, HA Baxi, JN Shah, A  Medina, S Banai, First In Man: Multislice CT Angiography Visualization Of An Innovative First-in-man Coronary Sinus Reducer Stent In Patients With Refractory Angina,2006

  1. K. Parikh, HA. Shah, AM. Naik, HA. Baxi, MC. Chag, UG. Shah, A. Hjalmarson, Y. Rozenman, First in Man: non invasive measurement of variation in Pulmonary artery pressure following exercise in heart failure patients using an innovative implantable device involving acoustic telemetry,2006

  1. MC. Chag, HA. Shah, AM. Naik, HA. Baxi, UG. Shah, AH. Chandarana, Y. Rozenman, KH. Parikh, First-In-Man: Comparison of impressure device measuring pulmonary artery pressure non-invasively with conventional contrast echocardiography In Congestive Heart Failure,2006

  1. Parikh KH, shah HP, Naik AM, Chag MC, Shah UG, Baxi HA, Chandarana AH, Shah JN, Waagstein F, H Jalmanson A, Razenman Y, First in man: Papirus-monitoring Pulmonary artery Pressure by Implantable device Responsible to Ultrasonic signals.2006

  1. Parikh KH, shah HP, Naik AM, Chag MC, Shah UG,Baxi HA, Chandarana AH, Shah JN, Waagstein F, H Jalmanson A, Razenman Y. Effect of Metoprolol XL on pulmonary artery pressure in patients with heart failure measured using first in human implantable Device responding to ultrasonic signal.  2006

  1. Parikh KH, Shah HD, Naik AM, Chag MC, Shah UG, Baxi HA, Chandarana AH, Shah JN, Waagstein F, H Jalmanson A, Razenman Y. Effect of Metaprolol XL on Diurnal variation in pulmonary arterial pressure in Heart failure patients using first-in-man implantable device responding to ultrasonic signals,2006 

  1. Parikh KH, Chag MC, Shah KJ, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Shah HD, Goyal RK. Intracoronary Boluses of Adenosine and Sodium Nitroprusside in Combination Reverses Slow/No-Reflow During Angioplasty: A Clinical Scenario of Ischemic Preconditioning. Can J Physiol Pharmacol. 2007;85(3-4):476-82.

  1. Hetal A Shah, Ajay M Naik, Hemang A Baxi, Milan C Chag, Urmil G Shah, Anish H Chandarana 2, Ramesh K. Goyal, Yoseph Rozenman, Keyur H Parikh,     First-in-man: effect of Metoprolol CR/XL uptitration on pulmonary artery pressure and its variation in chronic heart failure monitored non-invasively by an implanted device using ultrasonic signals 2007

  1. Parikh KH, Chag MC, Shah KJ, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Shah HD, Goyal RK,2007

  1. Shah HD, Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Shah KJ, Iyer S, Goyal RK, Beneficial Effects Of Addition Of Fenofibrate To Statin Therapy In Patients with Acute Coronary Syndrome After Percutaneous Coronary Interventions,2007

  1. Parikh KH, Shah HA, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Goyal RK. Efficacy of PercuSurge in Acute myocardial Infarction Patients Undergoing Revascularization With a Special Emphasis on Procedural Time. Indian Heart J 2008; 60(2):101-19.
  2. Parikh KH, Shah HA, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Goyal RK, Rozenman Y, Hjalmarson A, Effect of Metoprolol CR/XL on Pulmonary Artery Pressure in Chronic Heart Failure Patients Assessed by an Implanted Ultrasonic Device with Special Emphasis on Diurnal Variation and Exercise Capacity,2009

  1. Parikh KH, Shah HA, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Goyal RK, Rozenman Y, Hjalmarson A. Effect of Metoprolol CR/XL on Pulmonary Artery Pressure in Chronic Heart Failure Patients Assessed by an Implanted Ultrasonic Device with Special Emphasis on Diurnal Variation and Exercise Capacity. Indian Heart J 2009;61:34-9.
  2. Keyur Parikh, Ashok Seth, Hemang Baxi, Anish Chandarana, Satya Gupta, Urmil Shah, Milan Chag, Sandhya Nair, Praveen Chandra, First In Man Assessment of Orbital Atherectomy System in Treating De Novo Calcified Coronary Lesions (ORBIT I),2009

  1. Keyur Parikh, Milan Chag, Urmil Shah, Hemang Baxi, Anish Chanadarana, Ajay Naik, Satya Gupta, Shmuel Banai, Long Term Safety, Angina Relief and Improvement in Quality of Life in Patients with Refractory Angina Treated with the Neovasc Coronary Sinus Reducer,2009.

  1. Parikh Keyur, Naik Ajay, Gupta Satya, Baxi Hemang, Chandarana Anish, Shah Urmil,       Chag Milan, RemonCHF: Better Care for Congestive Heart Failure Patients,  Gujarat Medical Journal, Page 109,Issue-7, Volume-5, July 2010

  1. Naik Ajay, Chandarana Anish, Chag Milan, Gupta Satya, Baxi Hemang, Shah Urmil, Parikh Keyur, Neovasc Coronary Sinus Reducer: The Time Tested Option for “No Option” Patients, Gujarat Medical Journal, Page 111,Issue-7, Volume-5, July 2010.

  1. Parikh Keyur, Pandya Nilesh, Baxi Hemang, Chag Milan, Gupta Satya, Chandarana Anish, Naik Ajay, Shah Urmil, The Principal Investigator of ORBIT I Trial Discusses Safety and Performance of Diamondback 360° TM Orbital Atherectomy System in Treating de novo Calcified Coronary Lesions, Gujarat Medical Journal, Page 114,Issue-7, Volume-5, July 2010

  1. Chag Milan, Panchal Kanaiya,, Baxi Hemang, Chandarana Anish, Naik Ajay, Shah Urmil, Parikh Keyur, Initial Experience with CiTop™ ExPander™ Guidewire in Chronic Coronary Total Occlusion,  Gujarat Medical Journal, Page 117, Issue-7, Volume-5, July 2010.

  1. Chag Milan, Gupta Satya, Chandarana Anish, Shah Urmil, Baxi Hemang, Parikh Keyur, Transradial  Interventions: Our Experience, Gujarat Medical Journal, Page 127, Issue-7, Volume-5, July 2010.

  1. Satya Gupta,Abhi Patangay, Promadsingh Thakur, Elisa Vireca,Ajay Naik, Hemang Baxi, Urmil Shah, Anish Chandarana,Keyur Parikh, Third Heart Sounds Measured at CRT Device Implant Sites are Correlated to Echocardiographic Filling Parameters in Ambulatory Heart Failure Patient, 2011 HRS Abstract On TRAC HF Study.

  1. Satya Gupta,Abhi Patangay, Promadsingh Thakur, Elisa Vireca,Ajay Naik, Hemang Baxi, Urmil Shah, Anish Chandarana,Keyur Parikh, Transient Heart Rate Responses to Transitions in Posture in Ambulatory Heart Failure Patients are Correlated to BNP, Heart Failure Society of America 2011

      HFSA Abstract Number – 150398.

  1. Apurva Patel, Roosha Parikh, Parth Parikh, Milan Chag, Urmil Shah, Hemang Baxi, Anish Chandarana, Satya Gupta, Vineet Sankhla, Chintan Mehta, Neil Mehta, Jawahar Mehta, Parloop Bhatt, Keyur Parikh: A Hospital to Home Visit Model to Ensure Medical Compliance and Reduce Complications Following Percutaneous Coronary Intervention: A Novel Global Concept. Accepted as a presentation at the SCAI 2014

  1. Roosha Parikh, Apurva Patel, Shmuel Banai, Parth Parikh, Milan Chag, Urmil Shah, Hemang Baxi, Anish Chandarana, Ajay Naik, Satya Gupta, Vineet Sankhla, Parloop Bhatt, Keyur Parikh: A Possible Alternative Percutaneous Treatment for Patients with Disabling No-Option Angina: “Neovasc” Coronary Sinus Reducer Assessment – 8 Year Follow Up. Accepted as a poster presentation at the SCAI 2014

  1. Apurva Patel, Roosha Parikh, Parth Parikh, Milan Chag, Urmil Shah, Hemang Baxi, Anish Chandarana, Satya Gupta, Vineet Sankhla, Parloop Bhatt, Keyur Parikh: Orbital Atherectomy System in Treating Calcified Coronary Lesions: First in Man Assessment- 5 Year Follow Up. Accepted as a poster presentation at the SCAI 2014
  2. Satya Gupta, Parloop Bhatt, Milan Chag, Parth Parikh, Aditi Patel, Vatsal Chhaya, Anish Chandarana, Hemang Baxi, Urmil Shah, Dhiren Shah, Ajay Naik, Keyur Parikh. Temporal Trends in Young Indian Heart Failure Patients: A Ray of Hope, Accepted in SCAI 2016.

  1. Satya Gupta, Parloop Bhatt, Milan Chag, Parth Parikh, Aditi Patel, Roosha Parikh, Apurva Patel, Apurva Patel, Aditi Nanavati, Anish Chandarana, Hemang Baxi, Urmil Shah, Dhiren Shah, Ajay Naik, Keyur Parikh. Effect of Mono-therapy versus Combinational Therapy on Exercise Capacity of Pulmonary Arterial Hypertension Patients: Actual Care Data. Accepted in SCAI 2016.

  1. Satya Gupta, Parth Parikh, Aditi Patel, Apurva Patel, Roosha Parikh, Anish Chandarana, Milan Chag, Hemang Baxi, Urmil Shah, Keyur Parikh. Sustained Long Term Safety Outcomes of “NEOVASC” Coronary Sinus Reducer in No-Option Patients of Refractory Angina: 10 Year Follow-up Accepted in SCAI 2016.

  1. Milan Chag, Parloop Bhatt, Urmil Shah, Hemang Baxi, Anish Chandarana, Satya Gupta, Vineet Sankhla, Aditi Nanavati, Piyush Thakar, Keyur Parikh. Hospital to Home Visit, an Effective Health Care Initiative to Reduce Complications and Improve Drug Compliance and Adherence: NCDR® Participation Advantage, Accepted in NCDR 2016.

  1. Urmil  Shah,  Milan  Chag,  Dhiren  Shah,  Ajay  Naik,  Hemang  Baxi,  Anish  Chandarana, Satya Gupta, Vineet Sankhla, Keyur Parikh, Parloop Bhatt. NCDR® as a Resource to Develop Cardiac Disease Specific Clinical Care Clinics, Accepted in NCDR 2016.

  1. Urmil Shah, Milan Chag, Hemang Baxi, Anish Chandarana, Satya Gupta, Vineet Sankhla, Keyur Parikh, Parloop Bhatt. An Asian Indian  Single  Centre  Radial  Access  Percutaneous Coronary  Intervention Experience: NCDR® Findings, Accepted in NCDR 2016.

INTERNATIONAL AND NATIONAL CLINICAL TRIALS :

Indication of Trial

Clinical Phase of Trial (I-IV)

Role in Trial (e.g. Investigator, Co-Investigator)

Status

Ongoing /Completed

A multi-center, randomized, double-blind, active-controlled, parallel-group Phase 3 study to evaluate the efficacy and safety of LCZ696 compared to ramipril on morbidity and mortality in high risk patients following an acute myocardial infarction

Phase III

Principal Investigator

Upcoming

A randomized double-blind placebo-controlled trial for the evaluation of a polycap, low dose aspirin and vitamin D supplementation in primary prevention

Phase III

Principal Investigator

Follow up Ongoing

International Registry to assess medical Practice with longitudinal observation for Treatment of Heart Failure

Phase IV

Principal Investigator

Completed

DELiverability of Resolute Integrity Stent In all- Comer Vessels and Cross Over Stenting”.

Phase IV

Principal-Investigator

Completed

Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients with Chronic Heart Failure with Reduced Ejection Fraction : Recruitment Ongoing.

Phase IIIB

Co-Investigator

Recruitment Ongoing

MOZEC™ SEB PTCA: A prospective, multi-center, real world, post marketing surveillance (PMS) to evaluate safety and performance of the MOZEC Sirolimus Eluting Percutaneous Transluminal Coronary Angioplasty Balloon Dilatation Catheter for In-Stent Restenosis (ISR) patients or de novo coronary arteries in daily clinical practice.

Phase IV

Co-Investigator

Recruitment Ongoing

An Open-label, 2×2 Factorial, Randomized, Controlled, Clinical Trial to evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients with Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention.

Phase III

Co-Investigator

Recruitment Ongoing

Pulmonary Atrial Hypertension

Phase III

Co-Investigator

Follow up Ongoing

A Multinational, Randomised, Double-Blind, Placebo controlled Trial to Evaluate the Effect of  Ticagrelor 90 mg twice daily  on the Incidence of Cardiovascular Death, Myocardial Infarction or Stroke in Patients with Type 2 Diabetes Mellitus

Phase III

Co-Investigator

Follow up Ongoing

A Multicenter,  Randomized,  Double-Blind, Placebo-Controlled Trial  to  Evaluate  the  Effect  of Dapagliflozin  10  mg  Once  Daily  on the Incidence  of Cardiovascular  Death,  Myocardial Infarction  or Ischemic Stroke in  Patients  with Type  2 Diabetes

Phase III

Co-Investigator

Follow Up Ongoing

Ticagrelor with Aspirin or alone in high risk patients after coronary intervention

Phase III

Co-Investigator

Follow up Ongoing

A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study,  Cardiovascular Outcomes in Adult Subjects With Type 2 Diabetes Mellitus

Phase III

Co-Investigator

Competed

Asian Sudden Cardiac Death in Heart Failure

Registry

Co-Investigator

Follow up Ongoing

Improve Sudden Cardiac Arrest Study

Registry

Co-Investigator

Follow up Ongoing

Registry to Improve the Adoption of Consensus Treatment Guidelines.

Registry

Co-Investigator

Completed

To Evaluate The Role Of Radiation Protection Technology (CardiotrapTM) In Improving Radiation Safety In Diagnostic And Interventional Percutaneous Cardiology Procedures.

Registry

Co-Investigator

Completed

A prospective, single-arm, multi-centre, observational, real world, post-marketing surveillance to evaluate safety and performance of the BioMime™ Morph Sirolimus Eluting Coronary Stent System for very long coronary lesions

Registry

Co-Investigator

Ongoing

Safety and Efficacy of Axiostat hemostatic dressing on radial access after percutaneous procedure: A comparative open label study

Investigator initiative study

Co-Investigator

Completed

Evaluation of the Endeavor Resolute Zotarolimus-Eluting Coronary Stent System in a Patient Population with Long Lesion(s) and/or Dual Vessels in Asia .A Prospective, Multi-center, Non-randomized Study

Registry

Co-Investigator

Completed

Sinus node dysfunction registry phase 1

Registry

Co-Investigator

Completed

Sinus node dysfunction registry phase 2

Registry

Co-Investigator

Completed

New Guide wire for Crossing Total Occlusions in Coronary Arteries

First-in-Man

Co-Investigator

Completed

Platelet inhibition in Acute Coronary Syndromes

Phase III

Co-Investigator

Completed

A Multicenter, Randomized, Double-blind, Placebo-controlled Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events When AMG 145 is used in Combination With Statin Therapy In Patients with Clinically Evident Cardiovascular Disease.

Phase III

Co-Investigator

Completed

Prevention of Ischemic Vascular Events in Subjects with Acute Coronary Syndromes.

Phase II

Co-Investigator

Completed

Evaluation of the anti-anginal efficacy

Phase III

Co-Investigator

Completed

Long term follow up of antithrombotic management    patterns In Acute Coronary Syndrome patients in Asia

Phase IV

Co-Investigator

Completed

Investigate the association between HR and prognosis of patients with CAD treated with bisoprolol

Phase IV

Co-Investigator

Completed

Newly Diagnosed ACS and T2DM

Phase III

Co-Investigator

Completed

Registry of Atrial Fibrillation: Patient Characteristics and Clinical Management Practices

Phase IV

Co-Investigator

Completed

Unstable Angina/Non ST Segment Elevation Myocardial Infarction Scheduled to Undergo an Early Invasive Strategy

Phase III

Co-Investigator

Completed

Observational study of lipid profiles and treatment at presentation and after 12 weeks of statin therapy among Indian adults presenting with first coronary event

Phase IV

Co-Investigator

Completed

Monitoring Pulmonary Artery Pressure by Implantable Device Responding to Ultrasonic Signal (REMON Device)

Phase III

Co-Investigator

Completed

Flow improvement in patients with Acute Myocardial Infarction undergoing either conventional stenting or a strategy of primary aspiration followed by stenting using the Export® Aspiration Catheter: a Prospective, Randomized, Controlled Study

Phase III

Co-Investigator

Completed

To Evaluate the ‘Real World’ Clinical Performance of the Medtronic Endeavor™ ABT-578 Eluting Coronary Stent System.

Phase III

Co-Investigator

Completed

Randomized Evaluation of Long term anticoagulant therapy comparing Efficacy and safety of two blinded doses of dabigatran etexilate with open label warfarin for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: prospective, multi-centre, Parallel group, Non-inferiority trial.

Phase III

Co-Investigator

Completed

Open label, long-Term (1year) extension study of Pitavastatin 4 mg QD in Patients with Primary Hypercholesterolemia or combined Dyslipidemia

Phase III

Co-Investigator

Completed

The e-SELECT Registry : A Multicenter Post Marketing Survelliance

Phase IV

Co-Investigator

Completed

Early Glycoprotein IIb/IIIa Inhibition in Non-ST-segment Elevation Acute Coronary Syndrome: A Randomized, Placebo-Controlled Trial Evaluating the Clinical Benefits of Early Front-loaded Eptifibatide in the Treatment of Patients with Non – ST-segment Elevation Acute Coronary Syndrome (EARLY ACS)

Phase III

Co-Investigator

Completed

A Randomised, Double-blind, Parallel Group, Phase 3, Efficacy and safety study of AZD6140 Compares with Clopidogrel for prevention of Vascular Events in patients with Non-ST or ST Elevation Acute Coronary Syndromes (ACS) [PLATO – A study of PLATelet inhibition and Patient Outcomes.]

Phase III

Co-Investigator

Completed

Randomized, multinational, double-blind study, comparing a high loading dose regimen of Clopidogrel versus standard dose in patients with unstable angina or non-ST segment elevation myocardial infarction managed with an early invasive strategy

Phase III

Co-Investigator

Completed

A Randomized, double blind, Placebo-Controlled, Multicenter, Parallel Study Assessing the Efficacy, Safety, and Dose Response of Ramipril for the Treatment of Hypertension in Children and Adolescents

Phase III

Co-Investigator

Completed

Apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation: Active controlled randomized double blind parallel  arm study to evaluate efficacy and safety of Apixaban in subject with  non valvular Atrial fibrillation

Phase III

Co-Investigator

Completed

Multicenter, Randomized, double-blind – dummy, Parallel-group, Non-inferiority Trial Comparing the Efficacy and Safety of Once – daily oral Rivaroxabab (BAY 59 – 7939) with Adjusted – dose oral Warfarin for the prevention of Stroke and Non-central-nervous-system systemic embolism in Subjects with Non-valvular Atrial Fibrillation

Phase III

Co-Investigator

Completed

Patient Related Outcomes with Endeavor versus Cypher stenting Trial: Prospective, multicenter, randomized, two-arm, open-label trial

Phase III

Co-Investigator

Completed

A clinical trial comparing Cangrelor to Clopidogrel in subject who require Percutaneous Coronary Intervention

Phase III

Co-Investigator

Completed

A clinical Trial comparing treatment with Cangrelor (in combination with usual care) to usual care in subjects who require Percutaneous Coronary Intervention

Phase III

Co-Investigator

Completed

Randomized Dabigatran Etexilate dose finding study in patients with acute coronary syndromes post index Event with additional risk factors for cardiovascular complications also receiving aspirin and clopidogrel: Multi-centre, prospective, placebo controlled, group dose escalation trial

Phase III

Co-Investigator

Completed

A Multicenter, Randomized, parallel-group efficacy superiority study in hospitalize medically ill patients comparing rivaroxaban with Enoxaparin

Phase III

Co-Investigator

Completed

A multicenter, randomized, double-blind, assessor-blind, non-inferiority study comparing the efficacy and safety of once-weekly subcutaneous biotinylated idraparinux (SSR126517E) with oral adjusted-dose warfarin in the prevention of stroke and systemic thromboembolic events in patient with atrial fibrillation

Phase III

Co-Investigator

Completed

FREEDOM UT – 15C Studies (TDE-PH-302 and TDE-PH-304) conducted by United Therapeutics.

Phase III

Co-Investigator

Completed

Pilot study to evaluate the safety & performance or the diamond back 360TM orbit Atherectomy system in treating de-NOVO calcified coronary lesions – orbit -1

Phase III

Co-Investigator

Completed

CV 185-048: A Phase 3, Active (Aspirin) Controlled, Randomized, Double-Blind, Parallel arm Study to Evaluate the Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation

Phase III

Co-Investigator

Completed

Pacing System Post-Approval Study, Ahmedabad

Phase IV

Co-Investigator

Completed

Indian Heart Rhythm Society (IHRS) Registry of Atrial Fibrillation: Patient Characteristics and Clinical Management Practices

Phase IV

Co-Investigator

Completed

Long term follow up of antithrombotic management patterns In Acute Coronary Syndrome patients in Asia.

Phase III

Co-Investigator

Completed

Evaluation of the Safety and Efficacy of Short-term A-002 Treatment in Subjects with Acute Coronary Syndrome (ACS). VISTA-16: Vascular Inflammation Suppression to Treat Acute coronary syndrome for 16 weeks

Phase III

Co-Investigator

Completed

A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Phase IV Trial to Evaluate the effect of Sexagliptin on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke inn patient with Type 2 Diabetes)

Phase III

Co-Investigator

Completed

PAPER PRESENTATION:

  • Presented a paper on immediate and short term outcome of patients under going PTCA – study of first 23 Angioplasties of 232 lesion in first 200 patients in Gujarat- At CSI in 1998.
  • Presented paper on multi-valve dilatation of 30 patients- At CSI in 1999.
  • Presented a paper on Initial experience of stenting- At APG in Ahmedabad 2000
  • Presented a case in PTCA registry meeting in Cochin in March 2001.

ATTENDING CONFERENCES:

National conferences

  • CSI National Conference-Jaipur 1995, Calcutta, Madras
  • ECHO workshop- Delhi 1997.
  • PTCA registry meeting- Cochin 2001.

International Conferences

  • Asia-Pacific Interventional Cardiology workshop at Madras in 1996.
  • PCI Intervention course in Paris May 2001,
  • Interventional Cardiology workshop at Singapore in Oct 2001.
  • American College of Cardiology, meeting at Atlanta from 16th March to 20th March 2002.
  • To update knowledge in fast advancing field of Cardiology.

SPECIAL ACHIVEMENT:

  • Awarded fellowship by Cleveland Clinic Foundation, Ohio, U.S.A as International
  • Scholar in Interventional Cardiology Department especially for period of one month from 15th Feb to 15th March 2002
  • Saphaneous vein graft intervention with protection device
  • Carotid intervention with filter devices
  • IVUS
  • ASD Amplatzer devices
  • PFO device
  • Trans-esophageal Echocardiography
  • Intra-operative Echocardiography
  • Dobutamine Echocardiography
  • Septal artery ablation for HOCM

OTHER INVOLVEMENTS

  • Joined rotary as charter member in 2001 in rotary club of ahmedabad airport
  • President in year 2003/ 2004
  • Chairmen of cardiac awareness in 2004 / 2005
  • Chairman of sport activity in 2005 2006
  • Abhar function in 2008/ 2009 award giving ceremony in year
  • Vice Chairman of cardiac awareness 2009 1010 S
  • Chairman of cardiac awareness 2009 2017
  • Attended Various dis conferences and assembly
  • Multiple Cardiac awareness program and cardiac free check up nad camp echo
  • Speaker for heart disease prevention in intercity meet hosted by patan club
  • Assistant Governor, Zone 4 district 3050, 2010-2011

CAREER INTENTIONS:

  • Teaching medical students has been a pleasant hobby to me ever since I joined residency in General Medicine in 1989.
  • I am interested in working in an academic institution and university hospital. I enjoy educational activities and participate actively in academic and research programs.
  • I have given lectures in various medical associations in Gujarat, Conducted various CME programs and organized a live Echocardiography workshop at Sterling Hospital for the first time of its kind in State of Gujarat.
  • As a part of Care Cardiology Consultants I also actively participate in CME Programs for General Practitioners every month.
  • I am an active member of Care Cardiology Consultants’ JOURNAL CLUB of PHYSICIANS (MD)’. We hold a meeting every month to discuss the latest Journal Articles.

REFERENCE :

  1. Dr. Keyur Parikh

Chairman

            Care Institute of Medical Sciences

            Nr. Shukan Mall

            Off Science City Road, Sola

            Ahmedabad- 380060, Gujarat,

      

Your doctor believes in patient education. You will find a list of patient education videos here soon to get to know both your doctor and the disease better. CIMS Hospital in Ahmedabad and your doctor believes in transferring as much patient education knowledge as possible and is the process of uploading tons of patient education videos that can help you understand the disease or problems better.

CIMS Hospital was awarded being the best hospital in Gujarat for 2019 by the International Health Care Awards.

CIMS Hospital is a 350-bedded, multi-super speciality and regarded one of the best multi-speciality hospitals of Ahmedabad in Gujarat providing a range of diagnostic and treatment services.

CIMS Hospital has been awarded best hospital for quality in service delivery award at the ABP News presents Healthcare Leadership Awards 2015 held at Mumbai.

CIMS Hospital has been recognized as the Times Health Icon 2018 for being the best Hospital for Oncology and Critical Care. CIMS Hospital also was rated the Best Multispecialty Hospital in Gujarat at the International Healthcare Awards, 2018 held in Delhi.

CIMS Hospital provides world-class treatment and healthcare services in India and the leading heart hospital in Ahmedabad, Gujarat. CIMS Hospital offers the highest quality services and offers treatment to most diseases and medical problems with one of the highest success rates in India.

CIMS Hospital
Care Institute of Medical Sciences
Off Science City Road, Sola, Ahmedabad – 380060
Gujarat, INDIA

24x7 Helpline +91 70 69 00 00 00
Phone: +91 79 2771 2771 or 72
Fax: +91 79 2771 2770
Mobile: +91 98250 66664 or +91 98250 66668
Ambulance: +91 98244 50000
Email: info@cims.org

 

 

 

Forms

Organ Donation Registration Form
Job Application Form